|
Recommendations of good methods examples in the biomarker literature
|
|
4
|
79
|
November 23, 2021
|
|
Validity of comparing two different previously published cohort studies using IPTW for matching
|
|
5
|
312
|
November 11, 2021
|
|
Interpreting the random-effect solution in a mixed model
|
|
14
|
724
|
November 9, 2021
|
|
Interpretation of the REGEN-COV trial
|
|
22
|
795
|
November 1, 2021
|
|
Evidence Based Decision Making and Meta-Analysis -- An Information Theoretic Critique
|
|
0
|
337
|
October 27, 2021
|
|
Statistics Applied Using Threshold Science Fails to Deliver Progression Toward Truth
|
|
2
|
611
|
September 23, 2021
|
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
2
|
1554
|
September 22, 2021
|
|
Probability in state Ps(t) and Hazard ratio HR in Cox model
|
|
1
|
466
|
August 21, 2021
|
|
Logit Rank Plot by J.Copas in rms R package
|
|
6
|
518
|
August 20, 2021
|
|
Resources for Mixed-Effect Models in Medical Contexts
|
|
7
|
781
|
August 8, 2021
|
|
Interactions and random error
|
|
15
|
2737
|
July 17, 2021
|
|
Question arising from JAMA Guide article "Odds Ratios—Current Best Practice and Use"
|
|
19
|
6845
|
July 13, 2021
|
|
Statistical Misinterpretations and Clinical Practice Guidelines: any examples?
|
|
31
|
2877
|
June 28, 2021
|
|
Calculating SMD from geometric mean titers
|
|
2
|
835
|
May 26, 2021
|
|
The distinction between sample description (summarization) and point estimation
|
|
3
|
675
|
May 9, 2021
|
|
Another null misinterpretation in a study about the association of epidural analgesia and offspring risk of autism
|
|
6
|
1640
|
May 1, 2021
|
|
Validation of cox model
|
|
2
|
827
|
April 19, 2021
|
|
Find skewness and kurtosis of a bivariate scatterplot
|
|
1
|
664
|
March 29, 2021
|
|
Is there any intuition for the PRAUC metric?
|
|
0
|
753
|
March 24, 2021
|
|
Recommended Reading: Pay No Atttention to the Model Behind the Curtain by Philip B. Stark
|
|
0
|
766
|
March 11, 2021
|
|
Reporting Generalized Wilcoxon for Survival Analysis
|
|
6
|
1582
|
March 9, 2021
|
|
Musing on how to design "statistical functions/methods 2.0"
|
|
3
|
914
|
March 7, 2021
|
|
Bayesian Re-Analysis of Clinical Trial Data
|
|
19
|
6976
|
March 2, 2021
|
|
Hazard-ratio of marginal effects?
|
|
1
|
726
|
February 17, 2021
|
|
Early use of tocilizumab and steroids does not impact expansion or persistence of CAR T cells in B-ALL?
|
|
2
|
1028
|
February 17, 2021
|
|
Interpretation of P value
|
|
4
|
1666
|
December 31, 2020
|
|
Representative Covariate Settings
|
|
2
|
1345
|
December 27, 2020
|
|
Quality of remdesivir trials
|
|
41
|
5374
|
November 18, 2020
|
|
Proper analysis and presentation of the association between a continuous exposure and a binary outcome
|
|
1
|
1131
|
November 8, 2020
|
|
Can treatment B be superior after the RCT if it was thought that treatment A is superior before the RCT?
|
|
5
|
1365
|
October 13, 2020
|
